{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2014:AV7ZNIQJEVM4J54GCIB6AOLIDB","short_pith_number":"pith:AV7ZNIQJ","schema_version":"1.0","canonical_sha256":"057f96a2092559c4f7861203e03968185a5dfc0450d8319d486fb5cd2ee11f36","source":{"kind":"arxiv","id":"1406.2558","version":2},"attestation_state":"computed","paper":{"title":"Interim decision-making strategies in adaptive designs for population selection considering post-progression survival magnitudes","license":"http://creativecommons.org/licenses/by/3.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Chikuma Hamada, Ryuji Uozumi","submitted_at":"2014-06-10T14:01:17Z","abstract_excerpt":"The development of targeted therapies, which benefit only a subgroup of patients treated for a given type of cancer, has been extremely attractive to many investigators. Adaptive seamless phase II/III designs in oncology clinical trials with interim analyses for subpopulation selection could be used if pre-defined biomarker hypothesis exists. We consider the interim analysis using time-to-event endpoints, e.g., overall survival (OS) and progression-free survival (PFS), to identify whether the whole population or only the biomarker-positive population should be continued into the subsequent sta"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1406.2558","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by/3.0/","primary_cat":"stat.AP","submitted_at":"2014-06-10T14:01:17Z","cross_cats_sorted":[],"title_canon_sha256":"1bf666709ec05d8880e6953a495ce2cf92de9ef09f67eaaf034c385153b24bc7","abstract_canon_sha256":"0c55a2f5cbd03a3602a93864fe62d9515e22c714eeb330cf98bc768c5e0168ef"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T01:19:34.565381Z","signature_b64":"HFo35dbbF4+uB8cZFIhiQ1S3FitaolMASInKy93FCN5yKz2JepmS3CrL4+uSgabn1iWDmBNBoskJlMHaj+aGBA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"057f96a2092559c4f7861203e03968185a5dfc0450d8319d486fb5cd2ee11f36","last_reissued_at":"2026-05-18T01:19:34.564852Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T01:19:34.564852Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Interim decision-making strategies in adaptive designs for population selection considering post-progression survival magnitudes","license":"http://creativecommons.org/licenses/by/3.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Chikuma Hamada, Ryuji Uozumi","submitted_at":"2014-06-10T14:01:17Z","abstract_excerpt":"The development of targeted therapies, which benefit only a subgroup of patients treated for a given type of cancer, has been extremely attractive to many investigators. Adaptive seamless phase II/III designs in oncology clinical trials with interim analyses for subpopulation selection could be used if pre-defined biomarker hypothesis exists. We consider the interim analysis using time-to-event endpoints, e.g., overall survival (OS) and progression-free survival (PFS), to identify whether the whole population or only the biomarker-positive population should be continued into the subsequent sta"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1406.2558","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1406.2558","created_at":"2026-05-18T01:19:34.564935+00:00"},{"alias_kind":"arxiv_version","alias_value":"1406.2558v2","created_at":"2026-05-18T01:19:34.564935+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1406.2558","created_at":"2026-05-18T01:19:34.564935+00:00"},{"alias_kind":"pith_short_12","alias_value":"AV7ZNIQJEVM4","created_at":"2026-05-18T12:28:19.803747+00:00"},{"alias_kind":"pith_short_16","alias_value":"AV7ZNIQJEVM4J54G","created_at":"2026-05-18T12:28:19.803747+00:00"},{"alias_kind":"pith_short_8","alias_value":"AV7ZNIQJ","created_at":"2026-05-18T12:28:19.803747+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB","json":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB.json","graph_json":"https://pith.science/api/pith-number/AV7ZNIQJEVM4J54GCIB6AOLIDB/graph.json","events_json":"https://pith.science/api/pith-number/AV7ZNIQJEVM4J54GCIB6AOLIDB/events.json","paper":"https://pith.science/paper/AV7ZNIQJ"},"agent_actions":{"view_html":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB","download_json":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB.json","view_paper":"https://pith.science/paper/AV7ZNIQJ","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1406.2558&json=true","fetch_graph":"https://pith.science/api/pith-number/AV7ZNIQJEVM4J54GCIB6AOLIDB/graph.json","fetch_events":"https://pith.science/api/pith-number/AV7ZNIQJEVM4J54GCIB6AOLIDB/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB/action/timestamp_anchor","attest_storage":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB/action/storage_attestation","attest_author":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB/action/author_attestation","sign_citation":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB/action/citation_signature","submit_replication":"https://pith.science/pith/AV7ZNIQJEVM4J54GCIB6AOLIDB/action/replication_record"}},"created_at":"2026-05-18T01:19:34.564935+00:00","updated_at":"2026-05-18T01:19:34.564935+00:00"}